Cargando…
Identification of Drug-Disease Associations Using Information of Molecular Structures and Clinical Symptoms via Deep Convolutional Neural Network
Identifying drug-disease associations is helpful for not only predicting new drug indications and recognizing lead compounds, but also preventing, diagnosing, treating diseases. Traditional experimental methods are time consuming, laborious and expensive. Therefore, it is urgent to develop computati...
Autores principales: | Li, Zhanchao, Huang, Qixing, Chen, Xingyu, Wang, Yang, Li, Jinlong, Xie, Yun, Dai, Zong, Zou, Xiaoyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966717/ https://www.ncbi.nlm.nih.gov/pubmed/31998700 http://dx.doi.org/10.3389/fchem.2019.00924 |
Ejemplares similares
-
Seq-SymRF: a random forest model predicts potential miRNA-disease associations based on information of sequences and clinical symptoms
por: Li, Jinlong, et al.
Publicado: (2020) -
Identification of Potential Parkinson’s Disease Drugs Based on Multi-Source Data Fusion and Convolutional Neural Network
por: Liu, Jie, et al.
Publicado: (2022) -
Performance improvement for a 2D convolutional neural network by using SSC encoding on protein–protein interaction tasks
por: Wang, Yang, et al.
Publicado: (2021) -
Identification of MiRNA–Disease Associations Based on Information of Multi-Module and Meta-Path
por: Li, Zihao, et al.
Publicado: (2022) -
A Knowledge-Graph-Based Multimodal Deep Learning Framework for Identifying Drug–Drug Interactions
por: Zhang, Jing, et al.
Publicado: (2023)